HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of the platelet-activating factor antagonist BN 50739 and its diluents on mitochondrial respiration and membrane lipids during and following cerebral ischemia.

Abstract
Recent evidence suggests that platelet-activating factor plays a role in ischemia-induced neural injury. The Pulsinelli-Brierley four-vessel occlusion model was used to study the effect of a synthetic platelet-activating factor antagonist, BN 50739, and its solvents, either dimethyl sulfoxide or hydroxypropyl-beta-cyclodextrin, on cerebral ischemia-reperfusion. Rats were subjected to either 30 min of ischemia or 30 min of ischemia followed by 60 min of recirculation. Changes in the brain mitochondrial free fatty acid pool size, fatty acyl composition of phospholipids, and respiratory function were monitored. When the BN 50739 (2 mg of BN 50739/kg of body weight i.v.) was administered at the onset of recirculation, it significantly reversed the ischemia-induced accumulation of mitochondrial free fatty acids and loss of polyunsaturated fatty acyl chains from phosphatidylcholine and phosphatidylethanolamine while simultaneously improving mitochondrial respiration. Dimethyl sulfoxide alone decreased the mitochondrial level of malonyldialdehyde and total free fatty acid pool size, but there was no improvement in mitochondrial respiration. Hydroxypropyl-beta-cyclodextrin was reported to be pharmacologically inactive and capable of dissolving BN 50739. However, hydroxypropyl-beta-cyclodextrin alone also caused a significant increase in content of cerebral mitochondrial membrane free fatty acids and hydrolysis of phosphatidylcholine in normoxic control animals. The overall effect of BN 50739 on mitochondrial structure and energy metabolism supports the hypothesis that platelet-activating factor may play a key role in ischemia-induced cerebral injury.
AuthorsD Sun, D D Gilboe
JournalJournal of neurochemistry (J Neurochem) Vol. 62 Issue 5 Pg. 1929-38 (May 1994) ISSN: 0022-3042 [Print] England
PMID8158141 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Azepines
  • Fatty Acids, Nonesterified
  • Membrane Lipids
  • Phospholipids
  • Platelet Activating Factor
  • Triazoles
  • BN 50739
Topics
  • Animals
  • Azepines (pharmacology)
  • Brain (metabolism)
  • Fatty Acids, Nonesterified (metabolism)
  • Intracellular Membranes (drug effects, metabolism)
  • Ischemic Attack, Transient (metabolism)
  • Lipid Peroxidation (drug effects)
  • Male
  • Membrane Lipids (metabolism)
  • Mitochondria (drug effects, metabolism)
  • Oxygen Consumption (drug effects)
  • Phospholipids (metabolism)
  • Platelet Activating Factor (antagonists & inhibitors)
  • Prosencephalon
  • Rats
  • Rats, Sprague-Dawley
  • Triazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: